Promoting growth

AI-powered precision diagnostics for pathology

Peptide active ingredients for the treatment of highly metastatic carcinomas

Therapeutics against various autoimmune disorders

Design, research and development of non-coding RNA-based therapeutics for cardiovascular diseases

Digital health startup developing and operating a dynamic consent platform to connect data and material donors with researchers and clinicians

Decision support platform that helps dentists detect pathologies and restorations on dental x-ray images

Discovery and development of new chemical entities for treatment of acute and chronic liver diseases

Novel cell screening technologies for drug development

Qualitative and quantitative measurement of the biological decomposition of toxic waste (contaminated soil)

Novel optoacoustic imaging technology

Development of personalized T cell immunotherapies with a focus on haematological malignancies
Acquisition of Trianta in January 2014

Advisory service for the application of hyperthermia therapy

Development of small molecules using an innovative endogenous protective mechanism. Primary focus is the development of a first-in-class oral drug for…

Photoionization mass spectrometry for the direct analysis of complex organic gasses and solids

Diagnosing cortical bone health with ultrasound

Development of ATMPs based on recombinase driven error-free genome editing for eradication of life-threatening virus infection

Development of T cell receptors (TCRs) for T cell therapy of cancer 

Development of cancer therapies based on tubulysins

Development of pharmaceutical therapies for the treatment of airways-related diseases
Acquisition of Activaero in March 2014